Evidence map›Paper›PMID 34885800›Full record

ArticleMolecules (Basel, Switzerland)2021

Transporter Protein-Guided Genome Mining for Head-to-Tail Cyclized Bacteriocins.

Daniel Major, Lara Flanzbaum, Leah Lussier, Carly Davies, Kristian Mark P Caldo, Jeella Z Acedo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Characterization of the Novel Leaderless Bacteriocin, Bawcin, fromInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Modern Trends in Natural Antibiotic Discovery.Life (Basel, Switzerland) · 2023
    Review
  8. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniel MajorDepartment of Biology, Mount Royal University, Calgary, AB T3E 6K6, Canada.
Lara FlanzbaumDepartment of Biology, Mount Royal University, Calgary, AB T3E 6K6, Canada.ORCID 0000-0002-2401-1228
Leah LussierDepartment of Chemistry and Physics, Mount Royal University, Calgary, AB T3E 6K6, Canada.
Carly DaviesDepartment of Biology, Mount Royal University, Calgary, AB T3E 6K6, Canada.
Kristian Mark P CaldoDepartment of Agriculture, Food and Nutritional Science, University of Alberta, Edmonton, AB T6G 2P5, Canada.
Jeella Z AcedoDepartment of Chemistry and Physics, Mount Royal University, Calgary, AB T3E 6K6, Canada.ORCID 0000-0002-6648-770X
Mount Royal University · CAUniversity of Alberta · CA

Funding

Natural Sciences and Engineering Research Council RGPIN-2021-02607
6 · The paper itself

Abstract

Head-to-tail cyclized bacteriocins are ribosomally synthesized antimicrobial peptides that are defined by peptide backbone cyclization involving the N- and C- terminal amino acids. Their cyclic nature and overall three-dimensional fold confer superior stability against extreme pH and temperature conditions, and protease degradation. Most of the characterized head-to-tail cyclized bacteriocins were discovered through a traditional approach that involved the screening of bacterial isolates for antimicrobial activity and subsequent isolation and characterization of the active molecule. In this study, we performed genome mining using transporter protein sequences associated with experimentally validated head-to-tail cyclized bacteriocins as driver sequences to search for novel bacteriocins. Biosynthetic gene cluster analysis was then performed to select the high probability functional gene clusters. A total of 387 producer strains that encode putative head-to-tail cyclized bacteriocins were identified. Sequence and phylogenetic analyses revealed that this class of bacteriocins is more diverse than previously thought. Furthermore, our genome mining strategy captured hits that were not identified in precursor-based bioprospecting, showcasing the utility of this approach to expanding the repertoire of head-to-tail cyclized bacteriocins. This work sets the stage for future isolation of novel head-to-tail cyclized bacteriocins to serve as possible alternatives to traditional antibiotics and potentially help address the increasing threat posed by resistant pathogens.

Indexed as

Genome, BacterialAnti-Bacterial AgentsAntimicrobial PeptidesBacteriaBacteriocinsCyclizationMultigene FamilyPhylogenyAnti-Bacterial AgentsAntimicrobial PeptidesBacteriocinsantimicrobialscircular bacteriocinsgenome mininghead-to-tail cyclized bacteriocins

Identifiers

PMID34885800
PMCPMC8659200
OpenAlexW3216507911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.